Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Niessner

Showing results (121-130 of 207) with videos related to

Pageof 21
Sort By:
European Heart Journal|February 7, 2009
Prognostic value of apoptosis markers in advanced heart failure patientsAlexander Niessner, Philipp J Hohensinner, Kathrin Rychli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribingSeif El Hadidi, Giuseppe Rosano, Juan Tamargo, et al.
American Journal of Hypertension|December 19, 2024
Central vs. Brachial Blood Pressure and Pulse Pressure Amplification for Mortality Risk Prediction in Patients Undergoing Coronary AngiographyClara Daschner, Marcus E Kleber, Niklas Ayasse, et al.
Critical Care (London, England)|March 13, 2016
Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgeryChristian Roth, Lore Schrutka, Christina Binder, et al.
International Journal of Cardiology|November 3, 2022
Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trialSigrid Sandner, Adnan Kastrati, Alexander Niessner, et al.
Journal of Personalized Medicine|April 23, 2022
The Feasibility of Ultra-Sensitive Phonocardiography in Acute Chest Pain Patients of a Tertiary Care Emergency Department (ScorED Feasibility Study)Sebastian Schnaubelt, Felix Eibensteiner, Julia Oppenauer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trialsHeinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 29, 2025
Beyond Obesity: Metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiographyEva Steinacher, Andreas Hammer, Ulrike Baumer, et al.
Atherosclerosis|August 9, 2005
Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization?Alexander Niessner, Bernhard Richter, Martina Penka, et al.
European Journal of Clinical Investigation|June 29, 2021
BLS courses for refugees are feasible and induce commitment towards lay rescuer resuscitationSebastian Schnaubelt, Benedikt Schnaubelt, Arnold Pilz, et al.
Pageof 21

Showing results (121-130 of 207) with videos related to

Sort By:
Pageof 21
European Heart Journal|February 7, 2009
Prognostic value of apoptosis markers in advanced heart failure patientsAlexander Niessner, Philipp J Hohensinner, Kathrin Rychli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribingSeif El Hadidi, Giuseppe Rosano, Juan Tamargo, et al.
American Journal of Hypertension|December 19, 2024
Central vs. Brachial Blood Pressure and Pulse Pressure Amplification for Mortality Risk Prediction in Patients Undergoing Coronary AngiographyClara Daschner, Marcus E Kleber, Niklas Ayasse, et al.
Critical Care (London, England)|March 13, 2016
Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgeryChristian Roth, Lore Schrutka, Christina Binder, et al.
International Journal of Cardiology|November 3, 2022
Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trialSigrid Sandner, Adnan Kastrati, Alexander Niessner, et al.
Journal of Personalized Medicine|April 23, 2022
The Feasibility of Ultra-Sensitive Phonocardiography in Acute Chest Pain Patients of a Tertiary Care Emergency Department (ScorED Feasibility Study)Sebastian Schnaubelt, Felix Eibensteiner, Julia Oppenauer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trialsHeinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 29, 2025
Beyond Obesity: Metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiographyEva Steinacher, Andreas Hammer, Ulrike Baumer, et al.
Atherosclerosis|August 9, 2005
Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization?Alexander Niessner, Bernhard Richter, Martina Penka, et al.
European Journal of Clinical Investigation|June 29, 2021
BLS courses for refugees are feasible and induce commitment towards lay rescuer resuscitationSebastian Schnaubelt, Benedikt Schnaubelt, Arnold Pilz, et al.
Pageof 21